Alexanders vs Saul Centers
ALX and BFS side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ALX and BFS compare
Alexanders is the larger company, worth 1.8 times as much as Saul Centers ($1.3B against $701M).
On earnings, Alexanders is cheaper: it trades at 6.6× trailing earnings, against 30.8× for Saul Centers.
Saul Centers grew revenue faster over the last twelve months (9.2% versus 8.2% for Alexanders).
Alexanders keeps more of each dollar of sales as profit, with a net margin of 81.9% compared with 11.0% at Saul Centers.
Both pay dividends: Alexanders yields 5.5% and Saul Centers 8.3%.
Alexanders scores higher on the StockData Score (19 against 10 for Saul Centers), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ALX | BFS |
|---|---|---|
| Size and price | ||
| Market cap | $1.3B | $701M |
| Share price | $245.51 | $28.37 |
| Change, 1 year | 11.2% | −4.2% |
| Change, 5 years | −8.4% | −46.1% |
| Beta (5Y) | 0.63 | 0.74 |
| Employees | 69 | 70 |
| StockData Score | ||
| Total score | 19 (better) | 10 |
| Valuation score | 4 (better) | 2 |
| Growth score | 2 (better) | 1 |
| Performance score | 4 (better) | 3 |
| Health score | 4 (better) | 0 |
| Dividend score | 5 (better) | 4 |
| Valuation | ||
| P/E | 6.6× (better) | 30.8× |
| P/S | 5.4× | 2.3× (better) |
| P/B | 5.5× | 2.4× (better) |
| EV/EBITDA | – | 3.2× |
| Fair value | $642.99 | $54.79 |
| Margin of safety | 61.8% (better) | 48.2% |
| Growth | ||
| Revenue growth (TTM) | 8.2% | 9.2% (better) |
| Revenue growth, 5Y average | 1.4% | 5.2% (better) |
| Net income growth (TTM) | 421% (better) | −13.4% |
| EPS growth (TTM) | 421% (better) | −20.7% |
| EPS growth, 5Y average | −7.7% | −2.7% (better) |
| Profitability | ||
| Operating margin | – | 66.7% |
| Net margin | 81.9% (better) | 11.0% |
| Return on equity | 107% (better) | 11.1% |
| Return on invested capital | – | 55.4% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | 2.8× |
| Altman Z-score | 1.19 (better) | 0.47 |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 5.5% | 8.3% (better) |
| Payout ratio | 48.3% | 170% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | 0.00% | 2.2% (better) |
| Buyback yield | – | −0.81% |
| Shareholder yield | 5.5% | 7.5% (better) |
| Ownership | ||
| Held by institutions | 39.1% | 47.6% |
| Held by insiders | 48.7% | 4.2% |
| Insider net buying, 12 months | −$113K | $104K (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 11.5% | 2.3% |
Go deeper
- ALX stock overview
- ALX income statement
- ALX valuation and score
- BFS stock overview
- BFS income statement
- BFS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.